drugset / Trial / NCT00600977
Liposomal Anthracyclin in the Treatment of Elderly ALL
RandomizedParallel-groupOpen-labelTreatment
Summary
Phase II multicentric study comparing VAD regimen with continuous infusion over 96 hours of doxorubicin, vincristine and dexamethasone to a 90 minutes infusion of equivalent doses of Dox li-PEG, bolus infusion of vincristine and dexamethasone
Timeline
- Start
- 2002-03
- Primary completion
- —
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | 9 mg/m2 | Intravenous |
| Subject | Doxorubicin | Other / unclassified | 40 mg/m2 | Intravenous |
| Subject | Doxorubicine pegylated | Unknown | 40 mg/m2 | Intravenous |